Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00133380
Status:
COMPLETED
Last Update Posted:
2007-04-06
First Post:
2005-08-19
Brief Title:
A Study in People With High Cholesterol
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
PPAR Alpha LY518674 A Phase 2 Study of the Combinatorial Effect of LY518674 and Atorvastatin in Subjects With Hypercholesterolemia
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purposes of this study are to determine
The safety of the study medication and any side effects that might be associated with it
Whether the study medication can help patients with high levels of bad cholesterol low-density lipoprotein-cholesterol LDL-C alone or in combination with additional study medication
The safety of the study medication and any side effects that might be associated with it
Whether the study medication can help patients with high levels of bad cholesterol low-density lipoprotein-cholesterol LDL-C alone or in combination with additional study medication
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| H8D-MC-EMBF | None | None | None |